OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update

By admin | August 10, 2023

ROCKVILLE, Md., Aug. 10, 2023 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported its second quarter and first half of 2023 financial and operating results. Management will host an investor call to discuss quarterly results and provide a business update.

Additional Info

Publisher: GlobeNewswire Inc.
Contributor: OpGen, Inc.
Modified: Thu, 10 Aug 2023 20:15 GMT
Link: https://www.globenewswire.com/news-release/2023/08/10/2723188/35690/en/OpGen-Reports-Second-Quarter-2023-Financial-Results-and-Provides-Business-Update.html

OpGen